L. Chin, J. N. Andersen, and P. A. Futreal, Cancer genomics: from discovery science to personalized medicine, Nat Med, vol.17, p.297, 2011.

J. H. Doroshow and S. Kummar, Translational research in oncology-10 years of progress and future prospects, Nat Rev Clin Oncol, vol.11, p.649, 2014.

C. Kumar-sinha and A. M. Chinnaiyan, Precision oncology in the age of integrative genomics, Nat Biotechnol, vol.36, issue.1, pp.46-60, 2018.

J. Mateo, R. Dienstmann, E. M. Van-allen, C. Swanton, F. André et al., A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO scale for clinical Actionability of molecular targets (ESCAT), Ann Oncol, vol.29, issue.9, pp.1895-902, 2018.

E. Borcoman, L. Tourneau, C. Kamal, and M. , Molecular screening programs in different countries: what we learned and perspectives, Curr Opin Oncol, vol.31, issue.5, pp.445-53, 2019.

L. J. Tafe, I. P. Gorlov, F. B. De-abreu, J. A. Lefferts, X. Liu et al., Implementation of a molecular tumor board: the impact on treatment decisions for 35 patients evaluated at Dartmouth-Hitchcock Medical Center, Oncologist, vol.20, issue.9, pp.1011-1019, 2015.

S. A. Mcgraw, J. Garber, P. A. Jänne, N. Lindeman, N. Oliver et al., The fuzzy world of precision medicine: deliberations of a precision medicine tumor board, Pers Med, vol.14, issue.1, pp.37-50, 2017.

M. L. Mcgowan, R. S. Ponsaran, P. Silverman, L. N. Harris, and P. A. Marshall, A rising tide lifts all boats": establishing a multidisciplinary genomic tumor board for breast cancer patients with advanced disease, BMC Med Genomics, vol.9, issue.1, p.71, 2016.

A. H. Bryce, J. B. Egan, M. J. Borad, A. K. Stewart, G. S. Nowakowski et al., Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery, Oncotarget, vol.8, issue.16, pp.27145-54, 2017.

H. Stoeklé, M. Mamzer-bruneel, C. Frouart, L. Tourneau, C. Laurent-puig et al., Molecular tumor boards: ethical issues in the new era of data medicine, Sci Eng Ethics, vol.24, issue.1, pp.307-329, 2018.

A. Bardia, J. A. Iafrate, T. Sundaresan, J. Younger, and V. Nardi, Metastatic breast Cancer with ESR1 mutation: clinical management considerations from the molecular and precision medicine (MAP) tumor Board at Massachusetts General Hospital, Oncologist, vol.21, issue.9, pp.1035-1075, 2016.

T. C. Knepper, G. C. Bell, J. K. Hicks, E. Padron, J. K. Teer et al., Key lessons learned from Moffitt's molecular tumor board: the clinical genomics action committee experience, Oncologist, vol.22, issue.2, pp.144-51, 2017.

M. V. Ortiz, R. Kobos, M. Walsh, E. K. Slotkin, S. Roberts et al., Integrating genomics into clinical pediatric oncology using the molecular tumor Board at the Memorial Sloan Kettering Cancer Center, Pediatr Blood Cancer, vol.63, issue.8, pp.1368-74, 2016.

M. Schwaederle, B. A. Parker, R. B. Schwab, P. T. Fanta, S. G. Boles et al., Molecular tumor board: the University of California san Diego Moores Cancer Center experience, Oncologist, vol.19, issue.6, pp.631-637, 2014.

S. Harada, R. Arend, Q. Dai, J. A. Levesque, T. S. Winokur et al., Implementation and utilization of the molecular tumor board to guide precision medicine, Oncotarget, vol.8, issue.34, pp.57845-54, 2017.

C. Rolfo, P. Manca, R. Salgado, P. Van-dam, A. Dendooven et al., Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer, ESMO Open, vol.3, issue.5, p.398, 2018.

P. Horak, B. Klink, C. Heining, S. Gröschel, B. Hutter et al., Precision oncology based on omics data: The NCT Heidelberg experience, Int J Cancer, vol.141, issue.5, pp.877-86, 2017.

M. Patel, S. M. Kato, and R. Kurzrock, Molecular tumor boards: realizing precision oncology therapy, Clin Pharmacol Ther, vol.103, issue.2, pp.206-215, 2018.

Z. I. Mitri, S. Parmar, B. Johnson, A. Kolodzie, J. M. Keck et al., Implementing a comprehensive translational oncology platform: from molecular testing to actionability, J Transl Med, vol.16, issue.1, p.358, 2018.

M. Radovich, P. J. Kiel, S. M. Nance, E. E. Niland, M. E. Parsley et al., Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers, Oncotarget, vol.7, issue.35, pp.56491-500, 2016.

P. K. Mangat, S. Halabi, S. S. Bruinooge, E. Garrett-mayer, A. A. Janeway et al., Rationale and Design of the Targeted Agent and Profiling Utilization Registry Study, JCO Precis Oncol, vol.2, pp.1-14, 2018.

W. B. Dalton, P. M. Forde, H. Kang, R. M. Connolly, V. Stearns et al., Personalized medicine in the oncology clinic: implementation and outcomes of the Johns Hopkins molecular tumor board, JCO Precis Oncol, 2017.

R. K. Yin, Case study research and applications: design and methods, p.352, 2017.

D. Chakravarty, J. Gao, S. M. Phillips, R. Kundra, H. Zhang et al., OncoKB: a precision oncology knowledge base, JCO Precis Oncol, 2017.

S. E. Patterson, C. M. Statz, T. Yin, and S. M. Mockus, Utility of the JAX clinical knowledgebase in capture and assessment of complex genomic cancer data, Npj Precis Oncol, vol.3, issue.1, p.2, 2019.

X. Li and J. L. Warner, A review of precision oncology Knowledgebases for determining the clinical Actionability of genetic variants, Front Cell Dev Biol, vol.8, p.48, 2020.

B. M. Good, B. J. Ainscough, J. F. Mcmichael, A. I. Su, and O. L. Griffith, Organizing knowledge to enable personalization of medicine in cancer, Genome Biol, vol.15, issue.8, p.438, 2014.

I. Dagogo-jack and A. T. Shaw, Tumour heterogeneity and resistance to cancer therapies, Nat Rev Clin Oncol, vol.15, issue.2, pp.81-94, 2018.

D. L. Van-der-velden, C. Van-herpen, H. Van-laarhoven, E. F. Smit, H. Groen et al., Molecular tumor boards: current practice and future needs, Ann Oncol Off J Eur Soc Med Oncol, vol.28, issue.12, pp.3070-3075, 2017.

A. C. Edmondson, Teaming to innovate

A. C. Edmondson and J. Harvey, Cross-boundary teaming for innovation: integrating research on teams and knowledge in organizations, Hum Resour Manag Rev, vol.28, issue.4, pp.347-60, 2018.

J. A. Moscow, T. Fojo, and R. L. Schilsky, The evidence framework for precision cancer medicine, Nat Rev Clin Oncol, vol.15, issue.3, pp.183-92, 2018.

E. Minvielle, M. Waelli, C. Sicotte, and J. R. Kimberly, Managing customization in health care: a framework derived from the services sector literature, Health Policy, vol.117, issue.2, pp.216-243, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01509885

J. Lampel and H. Mintzberg, Customizing customization, Sloan Manag Rev, vol.38, issue.1, pp.21-30, 1996.

D. M. Berwick, What 'patient-centered' should mean: confessions of an extremist, Health Aff (Millwood), vol.28, issue.4, pp.555-65, 2009.

R. M. Epstein, K. Fiscella, C. S. Lesser, and K. C. Stange, Why the nation needs a policy push on patient-centered health care, Health Aff (Millwood), vol.29, issue.8, pp.1489-95, 2010.

K. L. Law and J. M. Rowe, Team-based care: views from community health center staff, Soc Work Health Care, vol.57, issue.4, pp.284-99, 2018.

, Publisher's Note

, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations